1. Home
  2. LCUT vs IKT Comparison

LCUT vs IKT Comparison

Compare LCUT & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$8.88

Market Cap

201.8M

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.63

Market Cap

215.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
IKT
Founded
1945
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.8M
215.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
LCUT
IKT
Price
$8.88
$1.63
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$5.00
$5.00
AVG Volume (30 Days)
180.7K
660.0K
Earning Date
05-07-2026
03-26-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
57.76
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$1.33
52 Week High
$9.80
$2.26

Technical Indicators

Market Signals
Indicator
LCUT
IKT
Relative Strength Index (RSI) 58.69 39.09
Support Level $3.44 $1.51
Resistance Level $9.80 $1.74
Average True Range (ATR) 0.81 0.09
MACD 0.04 -0.01
Stochastic Oscillator 65.23 38.46

Price Performance

Historical Comparison
LCUT
IKT

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

Share on Social Networks: